Clinical Trial Update: Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?

View source ↗

Summary

The trial is exploring whether serum YKL-40 can predict intrauterine growth restriction and preeclampsia, with the current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Preeclampsia

Snippet

Sponsor: Zealand University Hospital | Conditions: Intrauterine Growth Restriction, Preeclampsia | Status: UNKNOWN